Michael David Witcher
Impact in
- Aging top 5%
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Chromatin Remodeling and Cancer
- Genomics and Chromatin Dynamics
- RNA modifications and cancer
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
Papers in
-
- Epigenetics and DNA Methylation 9
- Genomics and Chromatin Dynamics 8
- Protein Degradation and Inhibitors 7
- RNA modifications and cancer 7
- Chromatin Remodeling and Cancer 4
- Retinoids in leukemia and cellular processes 3
- Oncology 10
- PARP inhibition in cancer therapy 6
- Co-authors
- Tatiana Shorstova (4 shared papers)Beverly M. Emerson (3 shared papers)William David Foulkes (4 shared papers)Maud Marques (12 shared papers)Khalid Hilmi (3 shared papers)Tiejun Zhao (7 shared papers)Christopher Vollmers (1 shared paper)Satchidananda Panda (1 shared paper)
- Journals
- Nucleic Acids Research (3 papers)Cancer Research (3 papers)Proceedings of the National Academy of Sciences (2 papers)Blood (2 papers)Blood Advances (2 papers)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Michael David Witcher
39 papers receiving 2.3k citations
Michael David Witcher's Hit Papers
Peers
Comparison fields: 5 of 113
- Aging 54
- Molecular Biology 1.6k
- Endocrine and Autonomic Systems 135
- Cancer Research 236
- Oncology 353
Countries citing papers authored by Michael David Witcher
This map shows the geographic impact of Michael David Witcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael David Witcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael David Witcher more than expected).
Fields of papers citing papers by Michael David Witcher
This network shows the impact of papers produced by Michael David Witcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael David Witcher. The network helps show where Michael David Witcher may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael David Witcher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Achieving clinical success with BET inhibitors as anti-cancer agents Hit paper breakdown → | 2021 | 272 |
| 2 | 2020 | 270 | |
| 3 | 2011 | 201 | |
| 4 | 2009 | 190 | |
| 5 | 2016 | 163 | |
| 6 | 2020 | 113 | |
| 7 | 2019 | 91 | |
| 8 | 2015 | 82 | |
| 9 | 2018 | 72 | |
| 10 | 2021 | 63 | |
| 11 | 2003 | 63 | |
| 12 | 2017 | 61 | |
| 13 | 2020 | 60 | |
| 14 | 2015 | 58 | |
| 15 | 2017 | 58 | |
| 16 | 2019 | 55 | |
| 17 | 2021 | 43 | |
| 18 | 2016 | 39 | |
| 19 | 2001 | 32 | |
| 20 | 2018 | 29 |
About Michael David Witcher
Michael David Witcher is a scholar working on Molecular Biology, Oncology, Hematology, Pathology and Forensic Medicine and Immunology, having authored 39 papers that have together received 2.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (9 papers), Genomics and Chromatin Dynamics (8 papers), Protein Degradation and Inhibitors (7 papers), RNA modifications and cancer (7 papers), PARP inhibition in cancer therapy (6 papers), Chromatin Remodeling and Cancer (4 papers), Retinoids in leukemia and cellular processes (3 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Aging (54 citations), Molecular Biology (1.6k citations), Endocrine and Autonomic Systems (135 citations), Cancer Research (236 citations) and Oncology (353 citations). Michael David Witcher has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Tatiana Shorstova, Beverly M. Emerson, William David Foulkes, Maud Marques, Khalid Hilmi, Tiejun Zhao, Christopher Vollmers, Satchidananda Panda, Maïka Jangal and Julie Secombe. Their work appears in journals such as Nucleic Acids Research, Cancer Research, Proceedings of the National Academy of Sciences, Blood and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.